A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer

NCT05759728 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

BIOLOGICAL: CNA3103: 5 x 10^7 cells
BIOLOGICAL: CNA3103: 1.5 x 10^8 cells
BIOLOGICAL: CNA3103: 4.5 x 10^8 cells
BIOLOGICAL: CNA3103: 1.5 x 10^9 cells
BIOLOGICAL: CNA3103: 2.5 x 10^7 cells
BIOLOGICAL: CNA3103: 6.75 × 10^8 cells

Sponsor

Carina Biotech Limited